EBS FY 2007 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$427M

FY 2007 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$183M+19.8% YoY

Gross Profit

$143M78.0% margin

Operating Income

$33M18.1% margin

Net Income

$23M12.5% margin

EPS (Diluted)

$0.77

Cash Flow

Operating Cash Flow

$55M

Free Cash Flow

$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$274M

Total Liabilities

$102M

Stockholders' Equity

$171M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$183M	$153M	+19.8%
Gross Profit	$143M	$129M	+10.9%
Operating Income	$33M	$38M	-13.0%
Net Income	$23M	$23M	+0.6%